Literature DB >> 14971887

Sabadinine: a potential non-peptide anti-severe acute-respiratory-syndrome agent identified using structure-aided design.

Jeffrey H Toney1, Sonia Navas-Martín, Susan R Weiss, Andreas Koeller.   

Abstract

A novel human coronavirus has been reported to be the causative agent of severe acute respiratory syndrome (SARS). Since replication of HcoVs depends on extensive proteolytic processing, the main proteinase, 3CLpro, is an attractive drug target for anti-SARS agents. We have employed molecular docking of a chemical database into the active site of 3CLpro to search for non-peptidyl inhibitors. One compound was identified to be the natural product sabadinine, isolated from a historical herbal remedy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14971887     DOI: 10.1021/jm034137m

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  15 in total

1.  Genomics approaches to synthesis plant-based biomolecules for therapeutic applications to combat SARS-CoV-2.

Authors:  Namisha Sharma; Mehanathan Muthamilarasan; Ashish Prasad; Manoj Prasad
Journal:  Genomics       Date:  2020-07-24       Impact factor: 5.736

2.  Synthesis and evaluation of isatin derivatives as effective SARS coronavirus 3CL protease inhibitors.

Authors:  Li-Rung Chen; Yu-Chin Wang; Yi Wen Lin; Shan-Yen Chou; Shyh-Fong Chen; Lee Tai Liu; Ying-Ta Wu; Chih-Jung Kuo; Tom Shieh-Shung Chen; Shin-Hun Juang
Journal:  Bioorg Med Chem Lett       Date:  2005-06-15       Impact factor: 2.823

3.  From genome to drug lead: identification of a small-molecule inhibitor of the SARS virus.

Authors:  Andrea J Dooley; Nice Shindo; Barbara Taggart; Jewn-Giew Park; Yuan-Ping Pang
Journal:  Bioorg Med Chem Lett       Date:  2005-12-01       Impact factor: 2.823

4.  Characterization of SARS-CoV main protease and identification of biologically active small molecule inhibitors using a continuous fluorescence-based assay.

Authors:  Richard Y Kao; Amanda P C To; Louisa W Y Ng; Wayne H W Tsui; Terri S W Lee; Hoi-Wah Tsoi; Kwok-Yung Yuen
Journal:  FEBS Lett       Date:  2004-10-22       Impact factor: 4.124

Review 5.  Natural product-derived phytochemicals as potential agents against coronaviruses: A review.

Authors:  Janice S Mani; Joel B Johnson; Jason C Steel; Daniel A Broszczak; Paul M Neilsen; Kerry B Walsh; Mani Naiker
Journal:  Virus Res       Date:  2020-04-30       Impact factor: 3.303

6.  The N-terminal octapeptide acts as a dimerization inhibitor of SARS coronavirus 3C-like proteinase.

Authors:  Ping Wei; Keqiang Fan; Hao Chen; Liang Ma; Changkang Huang; Lei Tan; Dong Xi; Chunmei Li; Ying Liu; Aoneng Cao; Luhua Lai
Journal:  Biochem Biophys Res Commun       Date:  2005-11-28       Impact factor: 3.575

7.  2-Substituted benzoxazinone analogues as anti-human coronavirus (anti-HCoV) and ICAM-1 expression inhibition agents.

Authors:  Pei-Wen Hsieh; Fang-Rong Chang; Cheng-Hsien Chang; Pei-Wen Cheng; Lien-Chai Chiang; Fu-Long Zeng; Kuei-Hsiang Lin; Yang-Chang Wu
Journal:  Bioorg Med Chem Lett       Date:  2004-09-20       Impact factor: 2.823

8.  High-throughput screening identifies inhibitors of the SARS coronavirus main proteinase.

Authors:  Jan E Blanchard; Nadine H Elowe; Carly Huitema; Pascal D Fortin; Jonathan D Cechetto; Lindsay D Eltis; Eric D Brown
Journal:  Chem Biol       Date:  2004-10

Review 9.  Virtual screening for the discovery of bioactive natural products.

Authors:  Judith M Rollinger; Hermann Stuppner; Thierry Langer
Journal:  Prog Drug Res       Date:  2008

10.  "Teaching old drugs to kill new bugs": structure-based discovery of anti-SARS drugs.

Authors:  Rajendram V Rajnarayanan; Sivanesan Dakshanamurthy; Nagarajan Pattabiraman
Journal:  Biochem Biophys Res Commun       Date:  2004-08-20       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.